CD34 and essential thrombocythemia: The results revealed that its expression was significantly lower in primary CD34+ and bone marrow mononuclear cells (BMMNCs) from patients with ET and PV, compared to those from healthy volunteers, at both mRNA and protein levels (Fig. 1a–c).